Krishna Bajjuri

This inventor holds 1 USPTO granted patent. Top assignee: Sutro Biopharma, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Krishna Bajjuri. Retrieved from https://idiyas.com/inventor/krishna-bajjuri-g4tywbpb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Krishna Bajjuri

Introduction

Krishna Bajjuri is an accomplished inventor known for his contributions to the field of biopharmaceuticals. He has made significant strides in developing innovative solutions that address critical medical challenges. His work is characterized by a commitment to advancing healthcare through scientific research and innovation.

Latest Patents

Krishna Bajjuri holds a patent for "Anti-Tissue Factor Antibodies and Antibody Conjugates, Compositions Comprising Anti-Tissue Factor Antibodies or Antibody Conjugates, and Methods of Making and Using Anti-Tissue Factor Antibodies and Antibody Conjugates." This patent reflects his expertise in creating novel therapeutic agents that have the potential to improve patient outcomes.

Career Highlights

Bajjuri is currently associated with Sutro Biopharma, Inc., where he continues to push the boundaries of biopharmaceutical research. His role at the company allows him to collaborate with other talented professionals in the field, contributing to groundbreaking projects that aim to enhance treatment options for various diseases.

Collaborations

Some of his notable coworkers include Amandeep Kaur Gakhal and Junhao Yang. Together, they work on innovative projects that leverage their collective expertise to drive advancements in biopharmaceuticals.

Conclusion

Krishna Bajjuri's work exemplifies the spirit of innovation in the biopharmaceutical industry. His contributions, particularly in the development of anti-tissue factor antibodies, highlight the importance of research and collaboration in creating effective medical solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…